Weil Advised Magellan Health in the $850M Sale of its Magellan Complete Care Business

Weil advised Magellan Health in the $850 million sale of its Magellan Complete Care business to Molina Healthcare, Inc. The transaction closed on January 04, 2021.

The Weil team that advised Magellan Health was led by Mergers & Acquisitions partner Raymond Gietz and included Mergers & Acquisitions associate Karl de la Roche. The team also included Tax partner Helyn Goldstein; Executive Compensation & Benefits partner Amy Rubin; Antitrust partner Steven Bernstein; Executive Compensation & Benefits associates Thomas McCarthy and Lauren Sawyer (Not Yet Admitted in New York); Technology & IP Transactions/Privacy associate Olivia Greer; and Antitrust associates Rob Meyer and Rachel Williams.